Study of blood clots in brain veins
Part of Blood & lymphatic, Brain & nervous system clinical trials.
This study follows people who have a blood clot in the brain’s venous drainage system. It aims to better understand this condition and may help improve how it is recognized and managed.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have a diagnosed blood clot in the brain veins (called cerebral venous thrombosis).
- Your diagnosis must be confirmed by an imaging test such as DSA, MRV, CTV, or high-resolution MRI.
- You (or your legal decision-maker) must be able to sign the informed consent.
- A trusted person or immediate family member (if acting for you) must also be able to sign consent.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses MRI scans to look at how fluid drainage and white matter are affected in people with narrowed or blocked veins in the brain. It aims to understand if these vein problems harm the brain's natural cleaning system.
This study is for people who have been diagnosed with cerebral venous thrombosis (a blood clot in the brain’s venous system) at specific hospitals. It looks back at cases from 2014 to 2023 to learn from real-world patients.
This trial tests a minimally invasive procedure to remove blood clots from veins in the brain (cerebral venous sinus thrombosis). If you've had symptoms like severe headache, seizures, or weakness within the past 3 weeks and imaging confirms a clot, this study may help restore blood flow and prevent serious complications.
This trial compares two blood thinners (dabigatran and apixaban) to see which works better for treating a blood clot in the brain's veins. It might help you if you have a new diagnosis of this type of clot and can take oral blood thinners.
This study compares two blood thinners (dabigatran and rivaroxaban) to see which works better for treating a blood clot in the brain's veins. You may be eligible if you have a new diagnosis of this type of stroke and can start treatment within 14 days.
This study looks at blood clots removed from the brain during a stroke procedure. Researchers want to understand what the clots are made of and how they relate to your blood tests, treatment success, and recovery.
Hear when a new Cerebral Venous Sinus Thrombosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.